Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)

Authors

Institutions

Publication Details

Journal
JAAD International
Published
2024-10-02
DOI
https://doi.org/10.1016/j.jdin.2024.09.001
Citations
7
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
3.74

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)

Andreas Pinter, Matthias Augustin, Rotraut Mößner, Ulrike Hüffmeier et al.
7 citations
JAAD International
Dermatology and Skin Diseases
3.74
article

Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)

Andreas Pinter, Matthias Augustin, Rotraut Mößner, Ulrike Hüffmeier, Sascha Gerdes, Petra Staubach, Nina Magnolo, Dagmar Wilsmann‐Theis, Robert Németh, Kerstin Wolk, Ansgar Weyergraf, Cornelia Paul, Robert Sabat, Jennifer Schmitz, Selina Patt
article en
7 citations

Abstract

No abstract available for this paper.
JAAD InternationalVol. 18
Goethe University Frankfurt (DE), University of Bonn (DE), Universität Hamburg (DE), Johannes Gutenberg University Mainz (DE), University Hospital Bonn (DE), Universitätsklinikum Erlangen (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), Zimmer Biomet (Germany) (DE), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Schleswig-Holstein (DE), Universitätsmedizin Göttingen (DE), University Hospital Frankfurt (DE), Charité - Universitätsmedizin Berlin (DE), B. Braun (Netherlands) (NL), University of Lübeck (DE)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Biogen, Celgene, Hexal AG, CSL Behring, Regeneron Pharmaceuticals, Dermira, Heising-Simons Foundation, BioCryst, Mylan, Incyte, Celltrion, Argenx, IC Design Education Center, Galderma, Medac, LEO Pharma, Novartis Pharma, Principia Biopharma, Janssen Pharmaceuticals, UCB Pharma, Cilag
Zero hunger
Openalex Percentile: Top 7%
Dermatology and Skin Diseases
3.74
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.